Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2013
10/24/2013WO2013134081A3 Halogenated compounds for photodynamic therapy
10/24/2013US20130281475 Inhibitors of c-fms kinase
10/24/2013US20130281465 Pyrazole derivative
10/24/2013US20130281461 Spirocyclic Heterocycles Medicaments Containing Said Compounds, Use Thereof And Method For Their Production
10/24/2013US20130281451 Indolin-2-one derivatives as protein kinase inhibitors
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281432 Pyridinones/pyrazinones, method of making, and method of use thereof
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281426 Pyridazinones, the preparation method and the use thereof
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130280211 Hepatitis C Virus Inhibitors
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651928A2 Anti-viral compounds
10/23/2013EP2651927A1 Anti-viral compounds
10/23/2013EP2651926A2 Anti-viral compounds
10/23/2013EP2651925A2 Anti-viral compounds
10/23/2013EP2651924A1 Anti-viral compounds
10/23/2013EP2651923A1 Anti-viral compounds
10/23/2013EP2651922A1 Indoles as respiratory syncytial virus antiviral agents
10/23/2013EP2651921A1 Insecticidal compounds
10/23/2013EP2651916A2 C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP2651889A1 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
10/23/2013EP2651888A1 New compounds for the treatment of neurodegenerative diseases
10/23/2013EP2651886A1 Method for depigmenting keratin materials using resorcinol derivatives
10/23/2013EP2651885A1 Anti-viral compounds
10/23/2013CN103370808A 有机电致发光装置 Organic electroluminescent device
10/23/2013CN103370314A Substituted benzopyrazin derivatives as FGFR kinase inhibitors for the treatment of cancer diseases
10/23/2013CN103360371A (E)-N-(2-amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts
10/23/2013CN103360370A Synthesis of nitroimidazole derivatives and application of nitroimidazole derivatives in field of antibacterial drugs
10/23/2013CN103360369A Erlotinib, and preparation method of new intermediate of erlotinib
10/23/2013CN103360317A Dicyclo-substituted pyrazolone azo derivatives, as well as preparation method and use thereof
10/23/2013CN102482512B Aqueous pigment dispersion and aqueous ink for ink jet recording
10/23/2013CN102249982B Pleuromutilin compound, and medical composition, preparation method and application thereof
10/23/2013CN102089287B Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes
10/22/2013US8563746 Cyclic benzimidazole derivatives useful as anti-diabetic agents
10/22/2013US8563738 Ligands for copper-catalyzed azide-alkyne cycloaddition reactions
10/22/2013US8563737 Methods of making bis-tridentate carbene complexes of ruthenium and osmium
10/22/2013US8563723 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
10/22/2013US8563715 Pyrimidine derivative having cell protecting effect and uses thereof
10/22/2013US8563585 Fullerene therapies for inflammation
10/22/2013US8563582 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/22/2013US8563566 Naphthyridine derivatives as potassium channel modulators
10/22/2013US8563565 Pyrazoloquinoline derivatives
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013US8562945 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
10/22/2013CA2619450C 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/22/2013CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/17/2013WO2013155483A1 Phototherapy devices and methods comprising optionally substitutted quinquiesphenyl compounds
10/17/2013WO2013154878A1 Heterocyclic compounds and uses thereof
10/17/2013WO2013154378A1 Novel nitrogen-containing heterocyclic compound and organic electronic device using same
10/17/2013WO2013154325A1 Novel organic electroluminescent compounds and organic electroluminescent device containing the same
10/17/2013WO2013153479A2 Indole and indazole compounds that activate ampk
10/17/2013WO2013153394A1 Quinolonones with antibacterial properties
10/17/2013WO2013153143A1 N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides
10/17/2013WO2013153055A1 Process for the preparation of a viral protease inhibitor in amorphous form
10/17/2013WO2013152712A1 3-cyanoanilinoalkylarylpiperazine derivative and use thereof in preparing drugs
10/17/2013WO2013152683A1 Bicycle substituted pyrazoloneazo derivatives and preparation method and use thereof
10/17/2013US20130274463 Process and intermediates for preparing macrolactams
10/17/2013US20130274279 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274260 New compounds for the treatment of neurodegenerative diseases
10/17/2013US20130274256 Novel inhibitors of bacterial biofilms and related methods
10/17/2013US20130274253 Novel pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/17/2013US20130274243 Chemical Compounds
10/17/2013US20130274242 Substituted pyrimidine compounds and their use as syk inhibitors
10/17/2013US20130274241 Indazolyl triazol derivatives
10/17/2013US20130274227 3,5-diaminopyrazole kinase inhibitors
10/17/2013US20130274218 Viral polymerase inhibitors
10/17/2013US20130273024 Methods for treating atherosclerosis
10/17/2013US20130270541 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device
10/17/2013US20130270524 Compound for organic light-emitting diode and organic light-emitting diode including the same
10/16/2013EP2650941A1 Organic electroluminescent element
10/16/2013EP2650291A1 Crystalline Antifungal Compounds
10/16/2013EP2649065A1 Bicyclic compounds as pim inhibitors
10/16/2013EP2649064A1 Novel triazole compounds iii
10/16/2013EP2649053A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/16/2013EP2649052A1 2 -aminobenz imidazole derivatives useful in the treatment of inflammation
10/16/2013EP2649051A1 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
10/16/2013EP2649050A1 Compounds
10/16/2013CN103354811A Insecticidal compounds
10/16/2013CN103354808A Anti-viral compounds
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351383A 5-fluorouracil nitroxyl-free-radical anti-tumor drug
10/16/2013CN103351382A Optimized synthesizing method of sunitinib malate
10/16/2013CN102250022B Substituted quinoxalinamine compounds, and preparation method and application thereof
10/16/2013CN102126963B Spirobifluorene amido compound and preparation method thereof
10/16/2013CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents
10/16/2013CN101679384B Novel amide derivative for inhibiting the growth of cancer cells
10/16/2013CN101600706B Akt活性抑制剂 Akt activity inhibitor
10/15/2013US8557983 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/15/2013US8557833 Aminopyrimidines useful as kinase inhibitors
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557821 Microbiocidal heterocycles
10/15/2013US8557819 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/15/2013US8557813 2-benzylpyridazinone derivatives as met kinase inhibitors
10/15/2013CA2731273C Processes and intermediates for preparing retroviral protease inhibitors
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 626